Vito Alessandro Lasorsa Selected Research

Vito Alessandro Lasorsa Research Topics

13	Neoplasms (Cancer) 04/2024 - 04/2016
13	Neuroblastoma 12/2023 - 04/2016
5	COVID-19 01/2022 - 01/2021
2	Infections 01/2022 - 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 05/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Cough 04/2021
1	Fever (Fevers) 04/2021
1	Fatigue 04/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Melanoma (Melanoma, Malignant) 09/2017

6	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 04/2016
3	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2019
2	Protein Isoforms (Isoforms)IBA 05/2024 - 01/2020
2	Vincristine (Oncovin)FDA LinkGeneric 09/2020 - 09/2020
1	HLA-DR Antigens (HLA-DR)IBA 04/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Neuropilin-1IBA 01/2022
1	EnzymesIBA 01/2022
1	InterleukinsIBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	CytokinesIBA 01/2022
1	LectinsIBA 01/2022
1	ChromatinIBA 01/2022
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Prothrombin (Factor II)IBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 05/2021
1	Immunoglobulin G (IgG)IBA 04/2021
1	Circulating Tumor DNAIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LuciferasesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	NucleotidesIBA 08/2016
1	Mitochondrial DNA (mtDNA)IBA 08/2016

2	Therapeutics 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 09/2020 - 01/2020
1	Precision Medicine 09/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Immunotherapy 09/2017